Treatment Satisfaction And Preference With Indacaterol/glycopyrronium Fixed-Dose Combination Therapy In Comparison To Tiotropium Monotherapy - Results Of The Favor Study

被引：0
|
作者：
Kardos, P. [1 ]
Hagedorn, I. [2 ]
机构：
[1] Red Cross Maingau Hosp, Allergy Resp & Sleep Med, Frankfurt, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6816
引用
收藏
页数：1
相关论文
共 50 条
  • [1] WHAT IS THE PATIENT'S PREFERENCE: TIOTROPIUM MONOTHERAPY OR FIXED-DOSE INDACATEROL/GLYCOPYRRONIUM COMBINATION THERAPY? - THE FAVOUR STUDY
    Kardos, P.
    Hagedorn, I.
    THORAX, 2015, 70 : A141 - A141
  • [2] The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study - the FAVOR study
    Kardos, Peter
    Hagedorn-Peinz, Ina
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 69 - 77
  • [3] INDACATEROL/GLYCOPYRRONIUM BROMIDE FIXED-DOSE COMBINATION FOR THE TREATMENT OF COPD
    Schachter, E. N.
    DRUGS OF TODAY, 2013, 49 (07) : 437 - 446
  • [4] Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD
    Prakash, Anoop
    Babu, K. Suresh
    Morjaria, Jaymin B.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 111 - 123
  • [5] Preference of COPD Patients for Therapy with Indacaterol/Glycopyrronium Fixed Dose Combination Compared to a Tiotropiummonotherapy- the FAVOR- Study
    Kardos, P.
    Hagedorn, I.
    INTERNIST, 2016, 57 : S27 - S27
  • [6] Efficacy and Safety of a Fixed-Dose Combination of Indacaterol and Glycopyrronium for the Treatment of COPD A Systematic Review
    Rodrigo, Gustavo J.
    Plaza, Vicente
    CHEST, 2014, 146 (02) : 309 - 317
  • [7] Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD
    Chan, Ming-Cheng
    Tan, Elise Chia-Hui
    Yang, Ming-Chin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 1079 - 1088
  • [8] Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study
    Hsieh, Meng-Jer
    Chen, Ning-Hung
    Cheng, Shih-Lung
    Tao, Chi-Wei
    Wei, Yu-Feng
    Wu, Yao-Kuang
    Chan, Ming-Cheng
    Liu, Shih-Feng
    Hsu, Wu-Huei
    Yang, Tsung-Ming
    Lin, Ming-Shian
    Liu, Ching-Lung
    Kuo, Ping-Hung
    Tsai, Ying-Huang
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 967 - 976
  • [9] Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma
    Perez de Llano, Luis
    Naval, Elsa
    Mejia, Natalia
    Dominguez-Ortega, Javier
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (01) : 1 - 15
  • [10] Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate as a fixed-dose combination in Japanese and Caucasian healthy subjects
    Tillmann, Hanns-Christian
    Inoue, Satoru
    Vaidya, Soniya
    Sakita, Yohei
    Machineni, Surendra
    Kobayashi, Kiyoshi
    Furihata, Kenichi
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345